Back to search

Article

Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study

2021-05-07

Abstract excerpt

<h4>Background: </h4> Immunomodulatory property of intravenous immunoglobulin (IVIG) has been used to counteract severe systemic inflammation in coronavirus disease 2019 (COVID-19). However, its use in acute respiratory distress syndrome (ARDS) due to COVID-19 pneumonia is not well established. <h4>Methods: </h4>: In this retrospective study, we analyzed electronic health records of COVID-19 patients admitted to i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
80446fcf-40cf-5f06-b462-a229d7f6d573
DOI
10.21203/rs.3.rs-468871/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort studyDOI 10.21203/rs.3.rs-468871/v2
Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in Covid19 Patients: Report of a Structured Multidisciplinary ConsensusSemantic proximity
The Saudi Critical Care Society Practice Guidelines on the Management of COVID-19 in the ICU: Therapy SectionSemantic proximity
Acute Respiratory Distress Syndrome in Patients with COVID-19 vs Non-COVID-19: Clinical characteristics and outcomes in a tertiary care setting in Mexico City.Semantic proximity
Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patientsSemantic proximity
Comparison of clinical characteristics and outcomes between COVID-19 survivors and non-survivors: a retrospective observational studySemantic proximity
Clinical characteristics associated with ARDS and mortality in patients with COVID-19 who received corticosteroid therapySemantic proximity
Comparing Outcomes and Predictors of Mortality in Critically-Ill ARDS Patients With Versus Without COVID-19: Prospective, Multivariable Analysis of 690 PatientsSemantic proximity
Course of inflammation and infection markers differ in ICU patients with severe COVID-19 under casirivimab- and/or tocilizumab application: an observational studySemantic proximity
Comparing Outcomes and Predictors of Mortality in Critically-Ill ARDS Patients with Versus Without COVID-19: Prospective, Multivariable Analysis of 690 PatientsSemantic proximity
On Whether Therapeutic Plasma Exchange is Effective Against Severe/Critical COVID-19 PneumoniaSemantic proximity
On whether therapeutic plasma exchange is an effective cure against severe/critical COVID-19 pneumoniaSemantic proximity
A Differential Therapeutic Consideration for use of Corticosteroids According to Established COVID-19 Clinical Phenotypes in Critically Ill PatientsSemantic proximity
Select a neighboring publication to make it the new centre.